Dr. Paul J. Mosca
Overview
My primary area of clinical interest is surgical oncology. My primary focus includes the care of patients with melanoma or other potentially aggressive skin or soft tissue tumors, as well as those in need of lymph node surgery. In addition to patient care and research, I am committed to education and training. It is important to me to be accessible, engaged, and thoughtful in my approach to interacting with patients, colleagues, learners, and other stakeholders. For me, a principle guiding force is a deep-seated belief in patient-centered, multidisciplinary, compassionate, state-of-the-art care that aims to serve our community and support the mission and values of Duke Health.
Dr. Mosca is rated as an Experienced provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Lymphofollicular Hyperplasia, Pancreaticoduodenectomy, and Lymphadenectomy.
His clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
120 E Carver St, Durham, NC 27704
Additional Areas of Focus
Dr. Mosca has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center Sarcoma Clinic
As an orthopaedic oncologist, I am passionate about providing the best diagnostic and therapeutic surgical care for patients with benign or malignant bone or soft tissue tumors of the musculoskeletal system. As the director of the Sarcoma program at the Duke Cancer Institute, my passion is building our team to provide the best clinical care and basic scientific, translational and clinical research to serve our patients. Dr. Brigman is rated as an Elite provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Bone Tumor, Undifferentiated Pleomorphic Sarcoma, Bone Graft, and Hip Replacement.
University Of North Carolina At Chapel Hill
Hong Kim is a Surgical Oncologist and a General Surgeon in Chapel Hill, North Carolina. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Kim is currently accepting new patients.
Duke Cancer Center
As an orthopedic oncologist, I treat cancers of the bone and muscle. My background is very different from most doctors. I started as a veterinarian and became interested in cancer because so many dogs have cancer, and I came to medical school to learn how to treat and beat some of these types of cancer. I’m still a veterinarian, and that’s a big part of what we do here. Many cancers of the bone and muscles, called sarcomas, are rare in people, but common in dogs. So continuing to treat dogs with this type of cancer lets us and our group gain a deeper understanding of how these cancers work. With my patients, I try to find out what the cancer has taken from them, and what their goals are for how to get back in control. For some, their goal is to beat the cancer no matter what. For others, the goal is to keep walking or to be able to walk again, or to be in less pain. Then we try to tailor our approach to the patient. Often, people think being a surgical oncologist must be a terrible job. But I find something in each patient to admire, because patients dealing with cancer develop a strength the rest of us don’t get to have. Dr. Eward is rated as a Distinguished provider by MediFind in the treatment of Mesenchymoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Desmoid Tumor, Bone Tumor, Hip Replacement, and Knee Replacement.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- MelanomaDr. Mosca isDistinguished. Learn about Melanoma.
- Advanced
- Merkel Cell CarcinomaDr. Mosca isAdvanced. Learn about Merkel Cell Carcinoma.
- Experienced
- Adult Soft Tissue SarcomaDr. Mosca isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Mosca isExperienced. Learn about Bone Tumor.
- CholecystitisDr. Mosca isExperienced. Learn about Cholecystitis.
- Epithelioid SarcomaDr. Mosca isExperienced. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Mosca isExperienced. Learn about Fibrosarcoma.
- Heart TransplantDr. Mosca isExperienced. Learn about Heart Transplant.